Motexafin gadolinium prolongs time to neurologic progression in lung cancer patients with brain metastases: results of a randomized phase III trial

Minesh P. Mehta; Patrick Rodrigus; C. Terhaard; A. Rao; John H. Suh; Wilson Roa; William Shapiro; Michael Glantz; Roy A. Patchell; Michael A. Weitzner

doi:10.1016/s0360-3016(02)03215-7

Motexafin gadolinium prolongs time to neurologic progression in lung cancer patients with brain metastases: results of a randomized phase III trial

Identifier:nobleid.org/w1/20260515/DFAB9FE7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFAB9FE7.svg?ark=w1%2F20260515%2FDFAB9FE7)](https://nobleid.org/work/w1/20260515/DFAB9FE7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Motexafin gadolinium prolongs time to neurologic progression in lung cancer patients with brain metastases: results of a randomized phase III trial

Identifier:nobleid.org/w1/20260515/DFAB9FE7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFAB9FE7.svg?ark=w1%2F20260515%2FDFAB9FE7)](https://nobleid.org/work/w1/20260515/DFAB9FE7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work